SEC Form 4 · accession 0001209191-15-022632
ChemoCentryx, Inc. · CCXI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Markus J. Cappel
Officer — Chief Bus. Officer & Treasurer
Period of report
Mar 2, 2015
Accepted (ET)
Mar 4, 2015 · 8:19 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 2, 2015 | M | 14,390 | $0.60 | A | 26,890 | D | |
| Common StockF2,F3 | Mar 2, 2015 | S | 14,390 | $8.1289 | D | 12,500 | D | |
| Common Stock | Mar 3, 2015 | M | 5,943 | $0.60 | A | 18,443 | D | |
| Common StockF2,F4 | Mar 3, 2015 | S | 5,943 | $7.8126 | D | 12,500 | D | |
| Common Stock | Mar 4, 2015 | M | 20,542 | $0.60 | A | 22,043 | D | |
| Common StockF2,F5 | Mar 4, 2015 | S | 20,542 | $7.9197 | D | 12,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F6 | $0.60 | Mar 2, 2015 | M | 14,390 | D | May 5, 2005 | May 5, 2015 | Common Stock | 14,390 | 60,610 | D |
| Stock Option (right to buy)F6 | $0.60 | Mar 3, 2015 | M | 5,943 | D | May 5, 2005 | May 5, 2015 | Common Stock | 5,943 | 54,667 | D |
| Stock Option (right to buy)F6 | $0.60 | Mar 4, 2015 | M | 20,542 | D | May 5, 2005 | May 5, 2015 | Common Stock | 20,542 | 34,125 | D |
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2Shares sold are associated with stock options which will expire in May 2015.
- F3Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.9525 to $8.31 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- F4Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.70 to $7.96 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- F5Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $7.62 to $8.03 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- F6As of March 2, 2015 and prior to this transaction, the option fully vested.